QNTM (Quantum BioPharma) Marketable Securities : $1.20 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Quantum BioPharma's Marketable Securities for the quarter that ended in Dec. 2024 was $1.20 Mil.

Quantum BioPharma's annual Marketable Securities increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.76 Mil) and increased from Dec. 2023 ($0.76 Mil) to Dec. 2024 ($1.20 Mil).

Quantum BioPharma Marketable Securities Historical Data

The historical data trend for Quantum BioPharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Marketable Securities Chart

Quantum BioPharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

0.16

0.02

0.76

1.20

Quantum BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															0.76	0.76	0.02	3.49	1.20

Quantum BioPharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Quantum BioPharma (NAS:QNTM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Quantum BioPharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Quantum BioPharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (NAS:QNTM) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

0K91:Germany QNTM:Canada

Address

55 University Avenue, Suite 1003, Toronto, ON, CAN, M5J 2H7

Website

https://www.fsdpharma.com

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.